drug · small molecule
varespladib methyl
Phase 2updated 3mo agoby Ophirex Inc🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 4 investigational indications.
targets
Group 10 secretory phospholipase A2Phospholipase A2, membrane associatedPhospholipase A2 group V
all catalysts(0)
nothing on the calendar yet
Trials studying varespladib methyl
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that